% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{DelTredici:272672,
author = {Del Tredici, Kelly and Schön, Michael and Feldengut,
Simone and Ghebremedhin, Estifanos and Kaufman, Sarah K and
Wiesner, Diana and Roselli, Francesco and Mayer, Benjamin
and Amunts, Katrin and Braak, Heiko},
title = {{E}arly {CA}2 {T}au {I}nclusions {D}o {N}ot {D}istinguish
an {A}ge-{R}elated {T}auopathy from {E}arly {A}lzheimer's
{D}isease.},
journal = {Journal of Alzheimer's disease},
volume = {101},
number = {4},
issn = {1387-2877},
address = {Amsterdam},
publisher = {IOS Press},
reportid = {DZNE-2024-01223},
pages = {1333 - 1353},
year = {2024},
abstract = {Neuropathologic studies of brains from autopsy series show
tau inclusions (pretangles, neuropils threads,
neurofibrillary tangles) are detectable more than a decade
before amyloid-β (Aβ) deposition in Alzheimer's disease
(AD) and develop in a characteristic manner that forms the
basis for AD staging. An alternative position views
pathological tau without Aβ deposition as a 'primary
age-related tauopathy' (PART) rather than prodromal AD.
Recently, an early focus of tau inclusions in the Ammon's
horn second sector (CA2) with relative sparing of CA1 that
occurs before tau inclusions develop in the entorhinal
cortex (EC) was proposed as an additional feature of PART.To
test the 'definite PART' hypothesis.We used
AT8-immunohistochemistry in 100μm sections to examine the
EC, transentorhinal cortex (TRE), and Ammon's horn in 325
brains with tau inclusions lacking Aβ deposits (average age
at death 66.7 years for females, 66.4 years for
$males).100\%$ of cases displayed tau inclusions in the TRE.
In $89\%$ of cases, the CA1 tau rating was greater than or
equal to that in CA2. In $25\%,$ CA2 was devoid of tau
inclusions. Only $4\%$ displayed a higher tau score in CA2
than in the TRE, EC, and CA1. The perforant path also
displayed early tau changes. APOE genotyping was available
for 199/325 individuals. Of these, $44\%$ had an ɛ4 allele
that placed them at greater risk for developing later NFT
stages and, therefore, clinical AD.Our new findings call
into question the PART hypothesis and are consistent with
the idea that our cases represent prodromal AD.},
keywords = {Humans / Alzheimer Disease: pathology / Alzheimer Disease:
metabolism / Alzheimer Disease: genetics / Female / Aged /
Male / Tauopathies: pathology / Tauopathies: metabolism /
tau Proteins: metabolism / Aged, 80 and over / Entorhinal
Cortex: pathology / Entorhinal Cortex: metabolism / Middle
Aged / CA2 Region, Hippocampal: pathology / CA2 Region,
Hippocampal: metabolism / Inclusion Bodies: pathology /
Inclusion Bodies: metabolism / Neurofibrillary Tangles:
pathology / Neurofibrillary Tangles: metabolism / Aging:
pathology / Aging: metabolism / APOE (Other) / Alzheimer’s
disease (Other) / Ammon’s horn (Other) / CA2 (Other) /
PART hypothesis (Other) / entorhinal cortex (Other) /
neurofibrillary tangles (Other) / pretangles (Other) / tau
seeding (Other) / tractus perforans (Other) / tau Proteins
(NLM Chemicals)},
cin = {AG Roselli},
ddc = {610},
cid = {I:(DE-2719)1910001},
pnm = {352 - Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39302368},
doi = {10.3233/JAD-240483},
url = {https://pub.dzne.de/record/272672},
}